Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating expenses:
Research and development	$ 7,786,056	$ 2,149,641
General and administrative	2,183,660	3,104,071
Total operating expenses	9,969,716	5,253,712
Operating loss	(9,969,716)	(5,253,712)
Other income:
Interest income	232,535	19,649
Total other income	232,535	19,649
Loss before income taxes	(9,737,181)	(5,234,063)
Income tax expense (benefit)	0	0
Net loss	$ (9,737,181)	$ (5,234,063)
Basic loss per common share	$ (1.19)	$ (0.64)
Diluted loss per common share	$ (1.19)	$ (0.64)
Weighted average number of common shares outstanding, basic	8,194,990	8,157,445
Weighted average number of common shares outstanding, diluted	8,194,990	8,157,445